Extension of Memorandum of Understanding Between the Food and Drug Administration and Servicio Nacional de Sanidad, Inocuidad y Calidad Agroalimentaria of the United Mexican States Concerning Entry of Mexican Cantaloupes Into the United States of America, 14030-14032 [2011-5944]

Download as PDF 14030 Federal Register / Vol. 76, No. 50 / Tuesday, March 15, 2011 / Notices this document. Submit electronic comments to https:// www.regulations.gov. Submit written comments to the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. It is only necessary to send one set of comments. It is no longer necessary to send two copies of mailed comments. Comments are to be identified with the docket number found in brackets in the heading of this document. In addition, when responding to specific discussion topics as outlined in this document, please identify the topic you are addressing. Received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday. III. Transcripts srobinson on DSKHWCL6B1PROD with NOTICES Please be advised that as soon as a transcript is available, it will be accessible at https:// www.regulations.gov. It may be viewed at the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. A transcript will also be available in either hardcopy or on CD–ROM, after submission of a Freedom of Information request. Written requests are to be sent to Division of Freedom of Information (HFI–35), Office VerDate Mar<15>2010 16:50 Mar 14, 2011 Jkt 223001 of Management Programs, Food and Drug Administration, 5600 Fishers Lane, rm. 6–30, Rockville, MD 20857. Dated: March 9, 2011. Leslie Kux, Acting Assistant Commissioner for Policy. [FR Doc. 2011–5950 Filed 3–14–11; 8:45 am] BILLING CODE 4160–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2011–N–0110] Extension of Memorandum of Understanding Between the Food and Drug Administration and Servicio Nacional de Sanidad, Inocuidad y Calidad Agroalimentaria of the United Mexican States Concerning Entry of Mexican Cantaloupes Into the United States of America AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is providing notice of an extension of memorandum of understanding (MOU) between FDA and Servicio Nacional de Sanidad, Inocuidad y Calidad Agroalimentaria of SUMMARY: PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 the United Mexican States. The purpose of the MOU is to establish, and build confidence in, a system that increases the likelihood that cantaloupes from Mexico offered for import into the United States comply with U.S. law. This MOU also establishes a risk-based classification system for firms in Mexico producing cantaloupes for import into the United States to protect the public health. DATES: The agreement became effective on October 26, 2005, amended on April 19, 2007, and extended on October 28, 2010, for 1 year. FOR FURTHER INFORMATION CONTACT: Naomi Kawin, Office of Global Engagement, Office of International Programs, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 31, rm. 3416, Silver Spring, MD 20993–0002, 301–796–8372, FAX: 301–595–7941. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 20.108(c), which states that all written agreements and MOUs between FDA and others shall be published in the Federal Register, the Agency is publishing notice of this MOU. Dated: March 9, 2011. Leslie Kux, Acting Assistant Commissioner for Policy. BILLING CODE 4160–01–P E:\FR\FM\15MRN1.SGM 15MRN1 VerDate Mar<15>2010 16:50 Mar 14, 2011 Jkt 223001 PO 00000 Frm 00064 Fmt 4703 Sfmt 4725 E:\FR\FM\15MRN1.SGM 15MRN1 14031 EN15MR11.048</GPH> srobinson on DSKHWCL6B1PROD with NOTICES Federal Register / Vol. 76, No. 50 / Tuesday, March 15, 2011 / Notices 14032 Reports Clearance Office on (301) 443– 1129. The following request has been submitted to the Office of Management and Budget for review under the Paperwork Reduction Act of 1995: [FR Doc. 2011–5944 Filed 3–14–11; 8:45 am] BILLING CODE 4160–01–C DEPARTMENT OF HEALTH AND HUMAN SERVICES Proposed Project: Children’s Hospitals Graduate Medical Education Payment Program (CHGME Payment Program) (OMB No. 0915–0247)—Revision Health Resources and Services Administration srobinson on DSKHWCL6B1PROD with NOTICES Agency Information Collection Activities: Submission for OMB Review; Comment Request Periodically, the Health Resources and Services Administration (HRSA) publishes abstracts of information collection requests under review by the Office of Management and Budget (OMB), in compliance with the Paperwork Reduction Act of 1995 (44 U.S.C. chapter 35). To request a copy of the clearance requests submitted to OMB for review, e-mail paperwork@hrsa.gov or call the HRSA VerDate Mar<15>2010 16:50 Mar 14, 2011 Jkt 223001 The CHGME Payment Program was enacted by Public Law 106–129 and reauthorized by Public Law 109–307 to provide Federal support for graduate medical education (GME) to freestanding children’s hospitals. This legislation attempts to provide support for GME comparable to the level of Medicare GME support received by other, non-children’s hospitals. The legislation indicates that eligible children’s hospitals will receive payments for both direct and indirect PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 medical education. Direct payments are designed to offset the expenses associated with operating approved graduate medical residency training programs and indirect payments are designed to compensate hospitals for expenses associated with the treatment of more severely ill patients and the additional costs relating to teaching residents in such programs. The CHGME Payment Program application forms received OMB clearance on June 30, 2010. Centers for Medicare and Medicaid Services (CMS) final rule regarding Sections 5503, 5504, 5505 and 5506 of the Affordable Care Act of 2010, Public Law 111–148, published in the Federal Register on Wednesday, November 24, 2010, requires some modification of the data collection within the CHGME Payment Program application. The CHGME Payment Program application forms have been E:\FR\FM\15MRN1.SGM 15MRN1 EN15MR11.049</GPH> Federal Register / Vol. 76, No. 50 / Tuesday, March 15, 2011 / Notices

Agencies

[Federal Register Volume 76, Number 50 (Tuesday, March 15, 2011)]
[Notices]
[Pages 14030-14032]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-5944]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2011-N-0110]


Extension of Memorandum of Understanding Between the Food and 
Drug Administration and Servicio Nacional de Sanidad, Inocuidad y 
Calidad Agroalimentaria of the United Mexican States Concerning Entry 
of Mexican Cantaloupes Into the United States of America

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is providing notice of 
an extension of memorandum of understanding (MOU) between FDA and 
Servicio Nacional de Sanidad, Inocuidad y Calidad Agroalimentaria of 
the United Mexican States. The purpose of the MOU is to establish, and 
build confidence in, a system that increases the likelihood that 
cantaloupes from Mexico offered for import into the United States 
comply with U.S. law. This MOU also establishes a risk-based 
classification system for firms in Mexico producing cantaloupes for 
import into the United States to protect the public health.

DATES: The agreement became effective on October 26, 2005, amended on 
April 19, 2007, and extended on October 28, 2010, for 1 year.

FOR FURTHER INFORMATION CONTACT:  Naomi Kawin, Office of Global 
Engagement, Office of International Programs, Food and Drug 
Administration, 10903 New Hampshire Ave., Bldg. 31, rm. 3416, Silver 
Spring, MD 20993-0002, 301-796-8372, FAX: 301-595-7941.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 20.108(c), which 
states that all written agreements and MOUs between FDA and others 
shall be published in the Federal Register, the Agency is publishing 
notice of this MOU.

    Dated: March 9, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
BILLING CODE 4160-01-P

[[Page 14031]]

[GRAPHIC] [TIFF OMITTED] TN15MR11.048


[[Page 14032]]


[GRAPHIC] [TIFF OMITTED] TN15MR11.049

[FR Doc. 2011-5944 Filed 3-14-11; 8:45 am]
BILLING CODE 4160-01-C

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.